Welcome to our dedicated page for Encompass Health news (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health stock.
Encompass Health Corp (EHC) operates one of the nation's largest networks of inpatient rehabilitation hospitals, offering post-acute care through advanced therapies and home health services. This page aggregates official press releases and verified news about the company's financial performance, operational developments, and healthcare innovations.
Investors and stakeholders will find timely updates on earnings reports, strategic partnerships, and regulatory compliance matters. Content spans facility expansions, technology implementations like DesignManufactureConstruct™, and service enhancements across rehabilitation and hospice care.
All materials are curated to provide a comprehensive view of EHC's market position without speculative commentary. Bookmark this page for direct access to primary sources about the company's progress in delivering coordinated, patient-centered care nationwide.
Encompass Health (NYSE: EHC) reported strong Q4 2024 results with significant growth across key metrics. Net operating revenue increased 12.7% to $1,405.0 million, driven by a 7.8% growth in discharges and 4.2% increase in net patient revenue per discharge. Same-store discharge growth was 5.8%.
The company's income from continuing operations per diluted share rose 25.5% to $1.18, while adjusted earnings per share increased 23.2% to $1.17. Cash flows from operating activities grew 38.7% to $278.8 million, and adjusted EBITDA improved 13.6% to $289.6 million.
For 2025, EHC provided guidance projecting net operating revenue between $5,800 to $5,900 million, adjusted EBITDA of $1,160 to $1,200 million, and adjusted earnings per share from continuing operations of $4.67 to $4.96.
Encompass Health (NYSE: EHC) has been named to Fortune's World's Most Admired Companies list for 2025, marking its fifth consecutive year receiving this recognition. As the nation's largest owner and operator of inpatient rehabilitation hospitals, this achievement highlights the company's commitment to exceptional patient care and stakeholder trust.
The selection process, conducted in collaboration with Korn Ferry, evaluated companies from an initial pool of the 1,000 largest U.S. companies by revenue and non-U.S. Global 500 companies with revenues exceeding $10 billion. The final list was narrowed to 650 companies across 30 countries. Companies were rated on nine criteria, including investment value, management quality, product quality, social responsibility, and talent attraction. Those scoring in the top half of their respective industries earned a place on the prestigious list.
Encompass Health (NYSE: EHC) has announced its schedule for reporting Q4 2024 financial results. The company will release its fourth quarter results, ending December 31, 2024, after market close on Thursday, February 6, 2025.
The company will hold an investor conference call the following day, Friday, February 7, 2025, at 10 a.m. ET. Investors can join via phone by dialing 800-579-2543 (US) or 785-424-1789 (International) using conference ID EHCQ424. A live webcast and replay will be available on the company's investor website.
Encompass Health (NYSE: EHC) has achieved recognition on Forbes' inaugural list of the Most Trusted Companies in America. The company, which stands as the nation's largest owner and operator of inpatient rehabilitation hospitals, secured the fourth position among companies in the Health Care Equipment and Services category.
The evaluation process, conducted in partnership with HundredX, Signal AI, and Glassdoor, examined over 2,000 large U.S.-based public companies. The assessment focused on four key areas: customer trust, employee trust, investor trust, and media sentiment, analyzing hundreds of millions of data points. Only 300 companies made the final list.
Mark Tarr, president and CEO, emphasized the company's dedication to being the trusted choice in inpatient rehabilitation and highlighted their commitment to providing compassionate, high-quality, individualized care to achieve optimal patient outcomes. The company aims to continue expanding its presence nationwide to meet service demands.
Encompass Health (NYSE: EHC) has announced preliminary plans to construct a 50-bed inpatient rehabilitation hospital in Bangor, Maine, at 1017 Union Street. The facility, set to open in 2027, will be the company's second hospital in Maine and will provide specialized care for patients recovering from various conditions including strokes, neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions.
The new hospital will feature private rooms, advanced rehabilitation technologies, an activities suite, in-house dialysis, pharmacy, and therapy courtyard. It will offer 24-hour nursing care along with physical, occupational, and speech therapies, delivered by specialized healthcare professionals.
Encompass Health and Enhabit have won a significant lawsuit in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The Court also ruled against private equity firms Vistria Group and Nautic Partners for aiding these breaches.
The Court found that the defendants misappropriated acquisition opportunities, used confidential information, and recruited key employees while still employed at Encompass Health. As compensation, the Court awarded 43% of VitalCaring Group's profits to Encompass Health and Enhabit, plus $1.62 million in mitigation damages and attorneys' fees.
The defendants were found to have deliberately concealed their actions through falsifying records, deleting evidence, and manipulating communications. The Court's decision sends a clear message about the consequences of breaching fiduciary duties and self-dealing by corporate officers.
Encompass Health and Enhabit have won a significant legal victory in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The court found that while employed at Encompass Health, these officers misappropriated acquisition opportunities, used confidential information, and recruited employees for a competing venture.
The Court awarded damages against private equity firms Vistria Group and Nautic Partners for aiding these breaches. The remedy includes a constructive trust entitling Encompass Health and Enhabit to 43% of VitalCaring Group's profits and future exit proceeds, approximately $1.62 million in mitigation damages, and attorneys' fees due to defendants' bad faith conduct including evidence tampering.
Encompass Health announced the opening of a new 61-bed inpatient rehabilitation hospital in Houston, Texas. This facility marks a significant milestone as the company's first hospital fully constructed using prefabricated modules. The innovative construction method, developed in collaboration with BLOX, utilized 80 uber-modules manufactured off-site and assembled on location. This approach resulted in enhanced quality control, reduced waste, and faster construction timelines. The hospital, located at 3010 Yellowstone Blvd., represents an evolution of a partnership that began in the early 2000s, progressing from bathroom pods to complete hospital prefabrication.
Encompass Health (NYSE: EHC) has announced plans to construct a 50-bed inpatient rehabilitation hospital in Wesley Chapel, Florida's Wiregrass Ranch community. The facility will provide specialized care for patients recovering from various conditions including strokes, neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions. The hospital will feature private rooms, advanced rehabilitation technologies, therapy facilities, and comprehensive medical services including 24-hour nursing care, physical, occupational, and speech therapies. Expected to open in 2027, the facility will join Encompass Health's national network of rehabilitation hospitals.
Encompass Health reported strong Q3 2024 results with net operating revenue increasing 11.9% to $1,351.0 million. The growth was driven by an 8.8% increase in discharges, including 6.8% same-store growth, and a 2.5% rise in net patient revenue per discharge. Income per diluted share grew 25.9% to $1.07, while adjusted EBITDA increased 13.4% to $269.3 million. The company raised its full-year 2024 guidance, with net operating revenue now expected between $5,325 to $5,375 million and adjusted earnings per share projected at $4.19 to $4.33.
FAQ
What is the current stock price of Encompass Health (EHC)?
What is the market cap of Encompass Health (EHC)?
